Dal Col et al. (2012) demonstrated that AKT is over-activated in MCL, and pharmacologic inhibition of Akt enhances the expression of pro-apoptotic BH3-only Noxa protein and represses the expression of anti-apoptotic Bcl-xL and Bfl-1 proteins. This evidence concerns the gene AKT1 and mantle cell lymphoma.